171 related articles for article (PubMed ID: 37086440)
1. The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus.
Papazoglou N; Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG
Rheumatology (Oxford); 2024 Jan; 63(1):50-57. PubMed ID: 37086440
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.
Frerix M; Stegbauer J; Kreuter A; Weiner SM
Arthritis Res Ther; 2014 Feb; 16(1):R54. PubMed ID: 24548804
[TBL] [Abstract][Full Text] [Related]
3. 7-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls.
Evangelatos G; Tentolouris N; Sfikakis PP; Tektonidou MG
Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38321577
[TBL] [Abstract][Full Text] [Related]
4. Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients.
Ajeganova S; Gustafsson T; Lindberg L; Hafström I; Frostegård J
Lupus Sci Med; 2020; 7(1):e000362. PubMed ID: 32095248
[TBL] [Abstract][Full Text] [Related]
5. Disease trends over time and CD4
Baragetti A; Ramirez GA; Magnoni M; Garlaschelli K; Grigore L; Berteotti M; Scotti I; Bozzolo E; Berti A; Camici PG; Catapano AL; Manfredi AA; Ammirati E; Norata GD
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):53-63. PubMed ID: 29150407
[TBL] [Abstract][Full Text] [Related]
6. Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.
Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG
Rheumatology (Oxford); 2018 Dec; 57(12):2158-2166. PubMed ID: 30102390
[TBL] [Abstract][Full Text] [Related]
7. Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus.
Bakshi J; Croca SC; Griffin M; Farinha F; Isenberg DA; Nicolaides A; Rahman A
Rheumatology (Oxford); 2022 Dec; 62(1):225-233. PubMed ID: 35482484
[TBL] [Abstract][Full Text] [Related]
8. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
McMahon M; Skaggs BJ; Grossman JM; Sahakian L; Fitzgerald J; Wong WK; Lourenco EV; Ragavendra N; Charles-Schoeman C; Gorn A; Karpouzas GA; Taylor MB; Watson KE; Weisman MH; Wallace DJ; Hahn BH
Arthritis Rheumatol; 2014 Jan; 66(1):130-9. PubMed ID: 24449580
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3 year prospective study.
Evangelatos G; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
Rheumatology (Oxford); 2022 Aug; 61(8):3408-3413. PubMed ID: 34850863
[TBL] [Abstract][Full Text] [Related]
11. Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations.
Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36759009
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study.
Jung JY; Kim HA; Lee HY; Suh CH
Int J Rheum Dis; 2019 Aug; 22(8):1410-1418. PubMed ID: 31050219
[TBL] [Abstract][Full Text] [Related]
13. Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.
Kiani AN; Post WS; Magder LS; Petri M
Rheumatology (Oxford); 2011 Nov; 50(11):2071-9. PubMed ID: 21875880
[TBL] [Abstract][Full Text] [Related]
14. Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.
Lourdudoss C; Elkan AC; Hafström I; Jogestrand T; Gustafsson T; van Vollenhoven R; Frostegård J
Lupus; 2016 Dec; 25(14):1602-1609. PubMed ID: 27334936
[TBL] [Abstract][Full Text] [Related]
15. Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.
Panopoulos S; Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
Lupus Sci Med; 2023 Mar; 10(1):. PubMed ID: 36868585
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.
David C; Divard G; Abbas R; Escoubet B; Chezel J; Chauveheid MP; Rouzaud D; Boutten A; Papo T; Dehoux M; Sacre K
Scand J Rheumatol; 2020 Jan; 49(1):33-37. PubMed ID: 31161842
[No Abstract] [Full Text] [Related]
17. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for changes in carotid intima media thickness and plaque over 5 years in women with systemic lupus erythematosus.
Lertratanakul A; Sun J; Wu PW; Lee J; Dyer A; Pearce W; McPherson D; Sutton-Tyrrell K; Thompson T; Barinas-Mitchell E; Ramsey-Goldman R
Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34876504
[TBL] [Abstract][Full Text] [Related]
19. Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus.
Thompson T; Sutton-Tyrrell K; Wildman RP; Kao A; Fitzgerald SG; Shook B; Tracy RP; Kuller LH; Brockwell S; Manzi S
Arthritis Rheum; 2008 Mar; 58(3):835-42. PubMed ID: 18311797
[TBL] [Abstract][Full Text] [Related]
20. Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.
Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Tektonidou MG
Semin Arthritis Rheum; 2018 Jun; 47(6):883-889. PubMed ID: 29150207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
